Almaty, Kazakhstan

Nurlan Abdikaliev

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nurlan Abdikaliev. Retrieved from https://idiyas.com/inventor/nurlan-abdikaliev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nurlan Abdikaliev: Innovator in Organic Chemistry

Introduction

Nurlan Abdikaliev is a notable inventor based in Almaty, Kazakhstan. He has made significant contributions to the field of organic chemistry, particularly through his innovative research and development of novel compounds.

Latest Patents

Abdikaliev holds a patent for ethyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts, which are designed to treat various medical conditions. This invention relates to the art of organic chemistry and introduces compounds that possess an antiarrhythmic effect. The general formula for these novel compounds includes variations where X can be Cl, Br, or I. He has 1 patent to his name.

Career Highlights

Throughout his career, Nurlan Abdikaliev has focused on advancing the understanding and application of organic chemistry. His work has been instrumental in developing compounds that can have significant therapeutic effects.

Collaborations

Abdikaliev has collaborated with esteemed colleagues in his field, including Felix Z Meerson and Gunar A Bremanis. These partnerships have contributed to the depth and breadth of his research.

Conclusion

Nurlan Abdikaliev is a prominent figure in organic chemistry, recognized for his innovative contributions and collaborative efforts. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…